CARM1 is required for proper control of proliferation and differentiation of pulmonary epithelial cells
Karen B. O’Brien(Harvard Stem Cell Institute), Susumu Kobayashi(Beth Israel Deaconess Medical Center), Elena Levantini(Istituto di Scienza e Tecnologie dell'Informazione "Alessandro Faedo"), Tyler Caron(Brigham and Women's Hospital), Meritxell Alberich-Jordà(Charles University), Annalisa Di Ruscio(Harvard Stem Cell Institute), Daniel G. Tenen(Harvard University), Scott J. Rodig(Brigham and Women's Hospital), Daehoon Kim(Yonsei University), Olivier Kocher(Beth Israel Deaconess Medical Center), Ulrich Steidl(Albert Einstein College of Medicine), Balázs Halmos(Montefiore Medical Center), Gang Huang(Shanghai Jiao Tong University), Alexander K. Ebralidze(Beth Israel Deaconess Medical Center), Neelu Yadav(HCG Cancer Centre), Mark T. Bedford(The University of Texas MD Anderson Cancer Center), Natasha Sng(Beth Israel Deaconess Medical Center), Manoj Bhasin(Emory University)
Cited by 4
Related Papers
Pembrolizumab plus Chemotherapy for Squamous Non–Small-Cell Lung Cancer
|New England Journal of Medicine|2018|3.7k
Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial
|Nature|2018|1.5k
Ibrutinib in Previously Treated Waldenström’s Macroglobulinemia
|New England Journal of Medicine|2015|937
Crizotinib in<i>ALK</i>-Rearranged Inflammatory Myofibroblastic Tumor
|New England Journal of Medicine|2010|871